ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Injection Immunoglobulin Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18J1073
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Subcutaneous Injection Immunoglobulin Market Insights Forecast to 2028
BUY CHAPTERS

Global Subcutaneous Injection Immunoglobulin Market Insights, Forecast to 2030

Code: QYRE-Auto-18J1073
Report
December 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
CSL Limited
Takeda

Subcutaneous Injection Immunoglobulin Market Size

The global Subcutaneous Injection Immunoglobulin market is projected to grow from US$ 1987 million in 2024 to US$ 2786.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.

Subcutaneous Injection Immunoglobulin Market

Subcutaneous Injection Immunoglobulin Market

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Report Covers:
This report presents an overview of global market for Subcutaneous Injection Immunoglobulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Subcutaneous Injection Immunoglobulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Subcutaneous Injection Immunoglobulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Subcutaneous Injection Immunoglobulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Subcutaneous Injection Immunoglobulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Subcutaneous Injection Immunoglobulin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Subcutaneous Injection Immunoglobulin Market Report

Report Metric Details
Report Name Subcutaneous Injection Immunoglobulin Market
Accounted market size in 2024 US$ 1987 million
Forecasted market size in 2030 US$ 2786.8 million
CAGR 5.8
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • 10% Purity
  • 20% Purity
Segment by Application
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Subcutaneous Injection Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Subcutaneous Injection Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Subcutaneous Injection Immunoglobulin Market growing?

Ans: The Subcutaneous Injection Immunoglobulin Market witnessing a CAGR of 5.8 during the forecast period 2025-2030.

What is the Subcutaneous Injection Immunoglobulin Market size in 2030?

Ans: The Subcutaneous Injection Immunoglobulin Market size in 2030 will be US$ 2786.8 million.

Who are the main players in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The main players in the Subcutaneous Injection Immunoglobulin Market are CSL

What are the Application segmentation covered in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The Applications covered in the Subcutaneous Injection Immunoglobulin Market report are Primary Immunodeficiency, Secondary Immunodeficiency, Others

What are the Type segmentation covered in the Subcutaneous Injection Immunoglobulin Market report?

Ans: The Types covered in the Subcutaneous Injection Immunoglobulin Market report are 10% Purity, 20% Purity

1 Study Coverage
1.1 Subcutaneous Injection Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 10% Purity
1.2.3 20% Purity
1.3 Market by Application
1.3.1 Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Injection Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region
2.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region (2019-2024)
2.2.3 Global Subcutaneous Injection Immunoglobulin Revenue by Region (2025-2030)
2.2.4 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2019-2030)
2.3 Global Subcutaneous Injection Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.4 Global Subcutaneous Injection Immunoglobulin Sales by Region
2.4.1 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Subcutaneous Injection Immunoglobulin Sales by Region (2019-2024)
2.4.3 Global Subcutaneous Injection Immunoglobulin Sales by Region (2025-2030)
2.4.4 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers
3.1.1 Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2019-2024)
3.1.2 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Injection Immunoglobulin in 2023
3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturers
3.2.1 Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2019-2024)
3.2.2 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Injection Immunoglobulin Revenue in 2023
3.3 Global Key Players of Subcutaneous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Subcutaneous Injection Immunoglobulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Subcutaneous Injection Immunoglobulin Sales by Type
4.1.1 Global Subcutaneous Injection Immunoglobulin Historical Sales by Type (2019-2024)
4.1.2 Global Subcutaneous Injection Immunoglobulin Forecasted Sales by Type (2025-2030)
4.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type
4.2.1 Global Subcutaneous Injection Immunoglobulin Historical Revenue by Type (2019-2024)
4.2.2 Global Subcutaneous Injection Immunoglobulin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Subcutaneous Injection Immunoglobulin Price by Type
4.3.1 Global Subcutaneous Injection Immunoglobulin Price by Type (2019-2024)
4.3.2 Global Subcutaneous Injection Immunoglobulin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Subcutaneous Injection Immunoglobulin Sales by Application
5.1.1 Global Subcutaneous Injection Immunoglobulin Historical Sales by Application (2019-2024)
5.1.2 Global Subcutaneous Injection Immunoglobulin Forecasted Sales by Application (2025-2030)
5.1.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application
5.2.1 Global Subcutaneous Injection Immunoglobulin Historical Revenue by Application (2019-2024)
5.2.2 Global Subcutaneous Injection Immunoglobulin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Subcutaneous Injection Immunoglobulin Price by Application
5.3.1 Global Subcutaneous Injection Immunoglobulin Price by Application (2019-2024)
5.3.2 Global Subcutaneous Injection Immunoglobulin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Subcutaneous Injection Immunoglobulin Market Size by Type
6.1.1 US & Canada Subcutaneous Injection Immunoglobulin Sales by Type (2019-2030)
6.1.2 US & Canada Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2030)
6.2 US & Canada Subcutaneous Injection Immunoglobulin Market Size by Application
6.2.1 US & Canada Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
6.2.2 US & Canada Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
6.3 US & Canada Subcutaneous Injection Immunoglobulin Market Size by Country
6.3.1 US & Canada Subcutaneous Injection Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
6.3.3 US & Canada Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Subcutaneous Injection Immunoglobulin Market Size by Type
7.1.1 Europe Subcutaneous Injection Immunoglobulin Sales by Type (2019-2030)
7.1.2 Europe Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2030)
7.2 Europe Subcutaneous Injection Immunoglobulin Market Size by Application
7.2.1 Europe Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
7.2.2 Europe Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
7.3 Europe Subcutaneous Injection Immunoglobulin Market Size by Country
7.3.1 Europe Subcutaneous Injection Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
7.3.3 Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Subcutaneous Injection Immunoglobulin Market Size
8.1.1 China Subcutaneous Injection Immunoglobulin Sales (2019-2030)
8.1.2 China Subcutaneous Injection Immunoglobulin Revenue (2019-2030)
8.2 China Subcutaneous Injection Immunoglobulin Market Size by Application
8.2.1 China Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
8.2.2 China Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Subcutaneous Injection Immunoglobulin Market Size by Type
9.1.1 Asia Subcutaneous Injection Immunoglobulin Sales by Type (2019-2030)
9.1.2 Asia Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2030)
9.2 Asia Subcutaneous Injection Immunoglobulin Market Size by Application
9.2.1 Asia Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
9.2.2 Asia Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
9.3 Asia Subcutaneous Injection Immunoglobulin Sales by Region
9.3.1 Asia Subcutaneous Injection Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Subcutaneous Injection Immunoglobulin Revenue by Region (2019-2030)
9.3.3 Asia Subcutaneous Injection Immunoglobulin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Country
10.3.1 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Grifols Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CSL Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Subcutaneous Injection Immunoglobulin Industry Chain Analysis
12.2 Subcutaneous Injection Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Injection Immunoglobulin Production Mode & Process
12.4 Subcutaneous Injection Immunoglobulin Sales and Marketing
12.4.1 Subcutaneous Injection Immunoglobulin Sales Channels
12.4.2 Subcutaneous Injection Immunoglobulin Distributors
12.5 Subcutaneous Injection Immunoglobulin Customers
13 Market Dynamics
13.1 Subcutaneous Injection Immunoglobulin Industry Trends
13.2 Subcutaneous Injection Immunoglobulin Market Drivers
13.3 Subcutaneous Injection Immunoglobulin Market Challenges
13.4 Subcutaneous Injection Immunoglobulin Market Restraints
14 Key Findings in The Global Subcutaneous Injection Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Grifols S A
CSL Limited
Takeda
List of Tables
    Table 1. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 10% Purity
    Table 3. Major Manufacturers of 20% Purity
    Table 4. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2019-2024)
    Table 9. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2025-2030)
    Table 10. Global Subcutaneous Injection Immunoglobulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Subcutaneous Injection Immunoglobulin Sales by Region (2019-2024) & (K Units)
    Table 12. Global Subcutaneous Injection Immunoglobulin Sales by Region (2025-2030) & (K Units)
    Table 13. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2019-2024)
    Table 14. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2025-2030)
    Table 15. Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Subcutaneous Injection Immunoglobulin Sales Share by Manufacturers (2019-2024)
    Table 17. Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Subcutaneous Injection Immunoglobulin Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Subcutaneous Injection Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Subcutaneous Injection Immunoglobulin Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Subcutaneous Injection Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Subcutaneous Injection Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection Immunoglobulin as of 2023)
    Table 23. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Product Offered and Application
    Table 25. Global Key Manufacturers of Subcutaneous Injection Immunoglobulin, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 28. Global Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 29. Global Subcutaneous Injection Immunoglobulin Sales Share by Type (2019-2024)
    Table 30. Global Subcutaneous Injection Immunoglobulin Sales Share by Type (2025-2030)
    Table 31. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Subcutaneous Injection Immunoglobulin Revenue Share by Type (2019-2024)
    Table 34. Global Subcutaneous Injection Immunoglobulin Revenue Share by Type (2025-2030)
    Table 35. Subcutaneous Injection Immunoglobulin Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Subcutaneous Injection Immunoglobulin Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 38. Global Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 39. Global Subcutaneous Injection Immunoglobulin Sales Share by Application (2019-2024)
    Table 40. Global Subcutaneous Injection Immunoglobulin Sales Share by Application (2025-2030)
    Table 41. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Subcutaneous Injection Immunoglobulin Revenue Share by Application (2019-2024)
    Table 44. Global Subcutaneous Injection Immunoglobulin Revenue Share by Application (2025-2030)
    Table 45. Subcutaneous Injection Immunoglobulin Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Subcutaneous Injection Immunoglobulin Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Subcutaneous Injection Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Subcutaneous Injection Immunoglobulin Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Subcutaneous Injection Immunoglobulin Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Subcutaneous Injection Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2025-2030) & (K Units)
    Table 73. China Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 74. China Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 75. China Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 78. China Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 79. China Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Subcutaneous Injection Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Subcutaneous Injection Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Subcutaneous Injection Immunoglobulin Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Subcutaneous Injection Immunoglobulin Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales by Country (2025-2030) & (K Units)
    Table 107. Takeda Company Information
    Table 108. Takeda Description and Major Businesses
    Table 109. Takeda Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Takeda Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Takeda Recent Developments
    Table 112. Grifols Company Information
    Table 113. Grifols Description and Major Businesses
    Table 114. Grifols Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Grifols Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Grifols Recent Developments
    Table 117. CSL Company Information
    Table 118. CSL Description and Major Businesses
    Table 119. CSL Subcutaneous Injection Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. CSL Subcutaneous Injection Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. CSL Recent Developments
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Subcutaneous Injection Immunoglobulin Distributors List
    Table 125. Subcutaneous Injection Immunoglobulin Customers List
    Table 126. Subcutaneous Injection Immunoglobulin Market Trends
    Table 127. Subcutaneous Injection Immunoglobulin Market Drivers
    Table 128. Subcutaneous Injection Immunoglobulin Market Challenges
    Table 129. Subcutaneous Injection Immunoglobulin Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Subcutaneous Injection Immunoglobulin Product Picture
    Figure 2. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Subcutaneous Injection Immunoglobulin Market Share by Type in 2023 & 2030
    Figure 4. 10% Purity Product Picture
    Figure 5. 20% Purity Product Picture
    Figure 6. Global Subcutaneous Injection Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Subcutaneous Injection Immunoglobulin Market Share by Application in 2023 & 2030
    Figure 8. Primary Immunodeficiency
    Figure 9. Secondary Immunodeficiency
    Figure 10. Others
    Figure 11. Subcutaneous Injection Immunoglobulin Report Years Considered
    Figure 12. Global Subcutaneous Injection Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Subcutaneous Injection Immunoglobulin Revenue 2019-2030 (US$ Million)
    Figure 14. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2019-2030)
    Figure 16. Global Subcutaneous Injection Immunoglobulin Sales 2019-2030 ((K Units)
    Figure 17. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Subcutaneous Injection Immunoglobulin Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Subcutaneous Injection Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Subcutaneous Injection Immunoglobulin Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Subcutaneous Injection Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Subcutaneous Injection Immunoglobulin Sales YoY (2019-2030) & (K Units)
    Figure 23. China Subcutaneous Injection Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Subcutaneous Injection Immunoglobulin Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Subcutaneous Injection Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Subcutaneous Injection Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Subcutaneous Injection Immunoglobulin in the World: Market Share by Subcutaneous Injection Immunoglobulin Revenue in 2023
    Figure 30. Global Subcutaneous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 32. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 33. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 34. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Subcutaneous Injection Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Subcutaneous Injection Immunoglobulin Sales Share by Country (2019-2030)
    Figure 41. U.S. Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 44. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 46. Europe Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Subcutaneous Injection Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 48. Europe Subcutaneous Injection Immunoglobulin Sales Share by Country (2019-2030)
    Figure 49. Germany Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 50. France Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 54. China Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 55. China Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 56. China Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 57. China Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 59. Asia Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 61. Asia Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Subcutaneous Injection Immunoglobulin Revenue Share by Region (2019-2030)
    Figure 63. Asia Subcutaneous Injection Immunoglobulin Sales Share by Region (2019-2030)
    Figure 64. Japan Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 68. India Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Subcutaneous Injection Immunoglobulin Sales Share by Country (2019-2030)
    Figure 75. Brazil Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Subcutaneous Injection Immunoglobulin Revenue (2019-2030) & (US$ Million)
    Figure 80. Subcutaneous Injection Immunoglobulin Value Chain
    Figure 81. Subcutaneous Injection Immunoglobulin Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Central Nervous System (CNS) Stimulant Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-21X3644
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Subcutaneous Injection Immunoglobulin Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-18J1073
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Cold Treatment Drug Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22L5796
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Phosphodiesterase (PDE) inhibitors Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-3P4044
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions